Dr James Teo Appointed to MHRA Working Group on AI Regulation in Healthcare

Dr James Teo, Consultant Neurologist (KCH) and Chief Medical Officer at the AI Centre, has been appointed to the Health Systems Working Group of the National Commission into the Regulation of AI in Healthcare, established by the Medicines and Healthcare products Regulatory Agency (MHRA).

Launched in September 2025, the National Commission brings together global experts in artificial intelligence, clinical practice, and health regulation to help shape a new framework governing AI use in healthcare. Chaired by Professor Alastair Denniston, with Professor Henrietta Hughes as Deputy Chair, the Commission will publish its final recommendations in 2026. Its work underpins commitments set out in the government’s 10-Year Health Plan and Life Sciences Sector Plan, aimed at transforming NHS services and accelerating growth within the UK’s life sciences industry.

As part of the Health Systems Working Group, Dr Teo will provide clinical and operational insights to guide development of regulatory approaches that ensure AI tools are deployed safely, effectively, and for maximum patient benefit. The group’s agenda covers critical topics such as post-market surveillance, pre-market approval processes, professional practice, and governance responsibilities for healthcare providers.

The Commission’s programme will run from November 2025 to May 2026, examining key areas including the continuous oversight of AI systems, model update controls, and the balance between developer autonomy and regulatory assurance.

Dr Teo’s appointment highlights the importance of bringing frontline clinical experience into national policy discussions to ensure that emerging AI regulation supports both innovation and patient safety.

Learn More:

MHRA National Commission on AI in Healthcare

MHRA Blog on MedTech Regulatory Reform